Setting the target for a better cervical screening test: Characteristics of a cost-effective test for cervical neoplasia screening

Obstetrics and Gynecology

Volumn 96, Issue 5, 2000, Pages 645-652

  Myers, Evan R ^a,b   McCrory, Douglas C ^a,b   Subramanian, Sujha ^a,b   McCall, Nancy ^a,b   Nanda, Kavita ^a,b   Datta, Santanu ^a,b   Matchar, David B ^a,b  

^a DURHAM VA MEDICAL CENTER   (United States)

^b Health Economics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER SCREENING; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROBABILITY; UTERINE CERVIX CANCER;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CERVIX NEOPLASMS; COST-BENEFIT ANALYSIS; FEMALE; HUMAN; MARKOV CHAINS; MASS SCREENING; MIDDLE AGE; SENSITIVITY AND SPECIFICITY; SUPPORT, NON-U.S. GOV'T; UNITED STATES; VAGINAL SMEARS;

EID: 0033791903     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(00)00979-0     Document Type: Article

References (36)

1. International incidence rates of invasive cervical cancer after introduction of cytologic screening
2. The epidemiological basis for evaluating screening policies
3. Reasons for cervical cancer despite extensive screening
4. Presentation of cervical cancer
5. Review of the screening history of Alberta women with invasive cervical cancer
6. Cost-effectiveness of 3 methods to enhance sensitivity of Papanicolaou testing
7. A model for the natural history of human papillomavirus infection and cervical carcinogenesis
8. Optimization of cervical cancer screening
9. Screening for cervical cancer
10. Cost effectiveness of cervical cancer screening for the elderly
11. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytological abnormalities: A systematic review
12. Meta-analysis of Pap test accuracy
13. Detecting premalignant cervical lesions. Contribution of screening colposcopy to cytology
14. Cervical cancer screening with cervicography and cytology
15. A comparison of simultaneous cervical cytology, HPV testing, and colposcopy
16. Evaluation of the ThinPrep Pap test as an adjunct to the conventional Pap smear
17. Laboratory implementation and efficacy assessment of the ThinPrep cervical cancer screening system
18. Consistency of a double PAPNET scan of cervical smears
19. Analysis of atypical squamous (glandular) cells of undetermined significance smears by neural network-directed review
20. A clinical trial of the AutoPap 300 QC system for quality control of cervicovaginal cytology in the clinical laboratory
21. The AutoPap 300 QC System multicenter clinical trials for use in quality control rescreening of cervical smears. I: A prospective intended use study
22. Effectiveness of automated cervical cytology rescreening using the AutoPap 300 QC System
23. Cervical biopsy-cytology correlation: A College of American Pathologists Q-Probes study of 22,439 correlations in 348 laboratories
24. Where's the high-grade neoplasia? The importance of minimally abnormal Papanicolaou diagnoses
25. Patterns of care for invasive cervical cancer: Results of a national survey of 1984 and 1990
26. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women
27. Vaginal changes and sexuality in women with a history of cervical cancer
28. Psychosocial effects of abnormal Pap tests and mammograms: A review
29. Identifying women with cervical neoplasia: Using human papillomavirus DNA testing for equivocal Papanicaloau results
30. Present evidence on the value of HPV testing for cervical cancer screening: A model-based exploration of the cost-effectiveness
31. Telomerase activity as a biomarker for (pre) neoplastic cervical disease in scrapings and frozen sections from patients with abnormal cervical smear